Text Size

Complications of Endocrine Surgery: Data From the United HealthSystem Consortium

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
University of Arkansas
ClinicalTrials.gov Identifier:
NCT01539499
First received: February 21, 2012
Last updated: March 21, 2013
Last verified: March 2013
History of Changes
  Purpose

The goal of this study is to help better determine the complication rates for endocrine surgery across the nation for both benign and malignant disease. It is our hypothesis that the complication rates are low overall and that malignant disease results in a higher complication rate than benign disease. This study will do a database review from all University HealthSystem Consortium (UHC).


Condition
Thyroid Disease
Parathyroid Disease
Endocrine Gland

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Retrospective
Official Title: Complications of Endocrine Surgery: Data From the United Health System Consortium

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by University of Arkansas:

Estimated Enrollment: 1000
Study Start Date: January 2010
Estimated Study Completion Date: December 2013
Estimated Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   18 Years to 90 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

The study will be conducted through a United HealthSystem Consortium query of endocrine surgery done as a primary procedure for specific diagnosis.

Criteria

Inclusion Criteria:

  • All patients between the ages of 18 and 90 years who have a diagnosis of benign multinodular goiter and/or malignant thyroid disease and have undergone a total thyroidectomy as a primary procedure.
  • Parathyroid patients will also be studied.

Exclusion Criteria:

  • Non endocrine surgery patients
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01539499

Locations
United States, Arkansas
University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States, 72205
Sponsors and Collaborators
University of Arkansas
Investigators
Principal Investigator: Brendan Stack, MD University of Arkansas
  More Information

No publications provided

Responsible Party: University of Arkansas
ClinicalTrials.gov Identifier: NCT01539499     History of Changes
Other Study ID Numbers: 112685
Study First Received: February 21, 2012
Last Updated: March 21, 2013
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Parathyroid Diseases
Thyroid Diseases
Endocrine System Diseases

ClinicalTrials.gov processed this record on May 21, 2013